Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.42 Insider Own8.50% Shs Outstand35.36M Perf Week6.44%
Market Cap759.53M Forward P/E- EPS next Y-1.93 Insider Trans-56.97% Shs Float32.35M Perf Month-17.57%
Income-50.73M PEG- EPS next Q-0.60 Inst Own55.46% Short Float7.55% Perf Quarter396.65%
Sales0.00M P/S- EPS this Y6.12% Inst Trans-1.57% Short Ratio1.79 Perf Half Y261.01%
Book/sh2.18 P/B9.84 EPS next Y19.83% ROA-72.72% Short Interest2.44M Perf Year325.35%
Cash/sh1.58 P/C13.56 EPS next 5Y- ROE-81.78% 52W Range3.60 - 28.15 Perf YTD256.22%
Dividend Est.- P/FCF- EPS past 5Y- ROI-97.28% 52W High-23.69% Beta1.30
Dividend TTM- Quick Ratio8.69 Sales past 5Y0.00% Gross Margin- 52W Low496.67% ATR (14)2.10
Dividend Ex-Date- Current Ratio8.69 EPS Y/Y TTM-0.31% Oper. Margin0.00% RSI (14)55.04 Volatility13.58% 9.46%
Employees33 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price41.88
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q18.44% Payout- Rel Volume0.46 Prev Close20.42
Sales Surprise- EPS Surprise18.08% Sales Q/Q- EarningsNov 02 AMC Avg Volume1.37M Price21.48
SMA200.17% SMA5023.33% SMA200135.31% Trades Volume624,695 Change5.19%
Date Action Analyst Rating Change Price Target Change
Feb-16-24Initiated Citigroup Buy $40
Oct-24-23Resumed Cantor Fitzgerald Overweight $16 → $35
Apr-27-23Initiated B. Riley Securities Buy $13
Apr-07-21Initiated Evercore ISI Outperform $35
Apr-06-21Initiated Guggenheim Buy $27
Apr-06-21Initiated Citigroup Buy $37
Apr-06-21Initiated Cantor Fitzgerald Overweight $32
Feb-02-24 04:30PM
Feb-01-24 08:30AM
Jan-17-24 05:51AM
Jan-08-24 04:05PM
Jan-05-24 08:50AM
09:40PM Loading…
Jan-03-24 09:40PM
Jan-02-24 04:37PM
Jan-01-24 04:47PM
Nov-29-23 08:30AM
Nov-24-23 09:35AM
Nov-21-23 04:00PM
05:05PM Loading…
Nov-14-23 05:05PM
Nov-13-23 02:46PM
Nov-08-23 09:55AM
Nov-03-23 04:01PM
Nov-02-23 07:16PM
Nov-01-23 08:30AM
Oct-05-23 04:05PM
Sep-19-23 08:30AM
Aug-31-23 04:00PM
Aug-30-23 04:01PM
Aug-23-23 08:30AM
Aug-10-23 08:49AM
Aug-03-23 04:01PM
04:00PM Loading…
Jun-26-23 04:00PM
May-12-23 06:06AM
May-09-23 04:00PM
May-01-23 08:50AM
Apr-14-23 08:50AM
Apr-11-23 04:00PM
Apr-07-23 09:55AM
Apr-05-23 07:00AM
Mar-07-23 09:55AM
Mar-06-23 09:48AM
Mar-02-23 04:01PM
Feb-23-23 04:31PM
Feb-10-23 04:01PM
Feb-07-23 09:03PM
Jan-14-23 08:00AM
Dec-05-22 08:30AM
Nov-29-22 08:30AM
Nov-08-22 08:30AM
Nov-03-22 08:30AM
Oct-25-22 09:00AM
Sep-29-22 04:01PM
Sep-01-22 04:01PM
Aug-04-22 04:05PM
Aug-03-22 08:30AM
Jun-07-22 08:30AM
Jun-01-22 08:30AM
May-18-22 07:07AM
May-12-22 08:30AM
May-05-22 04:05PM
Apr-01-22 08:30AM
Mar-23-22 04:01PM
Mar-22-22 04:01PM
Mar-21-22 04:01PM
Mar-03-22 04:05PM
Jan-05-22 08:30AM
Dec-09-21 07:52AM
Dec-06-21 10:00AM
Nov-17-21 08:30AM
Nov-11-21 08:30AM
Nov-04-21 04:05PM
Nov-02-21 08:30AM
Sep-21-21 08:30AM
Sep-10-21 09:47AM
Sep-08-21 07:00AM
Aug-31-21 08:30AM
Aug-09-21 08:30AM
Jun-12-21 05:58AM
May-10-21 04:05PM
Mar-11-21 09:44PM
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARENA PHARMACEUTICALS INCFormer 10% OwnerJan 25Sale24.253,978,54096,479,5950Jan 29 04:37 PM